New Delhi: Indian traditional medicine systems attracted huge international interest at a recent event in Delhi where, among others, Bangladeshi official Md. Razibul Habib, representing his country’s director general of drug administration, sought a presentation from an Indian ayurvedic medicine maker and a health centre head from Long Beach in California made inquiries about turmeric remedies.
Sanchit Sharma, executive director of Aimil pharmaceutical, said the response from international buyers and government regulators was encouraging at International Arogya 2017, an exhibition and conference on wellness organised by the ministry of Ayush along with department of commerce.
“Bangladesh government officials were given a demonstration at the recently inaugurated AII India Institute of Ayurveda in Sarita Vihar. They have also invited us to give a presentation for a possible introduction of Indian ayurvedic medicine in their country,” said Mr Sharma.
He said Indian ayurveda and other traditional medicines were gradually getting recognition in international markets like Europe, where Aimil’s anti-diabetic drug BGR-34 has got approval for sale.
Countries such as Sri Lanka, Mauritius and African nations, including Ghana, Ethiopia and Tanzania, too have shown interest in medicines like Lukoskin — a formulation for fighting leucoderma or depigmentation of skin — based on research conducted by the DRDO, he said.
Wellness experts from the US, Russia and Hungary showed keen interest in Indian traditional medicine and products, said H.B. Singh, former chief scientist of Council of Scientific & Industrial Research.
During discussions at Arogya 2017, Indian government officials suggested that ayurvedic system of medicine is likely to get a big push from a proposal to introduce MBBS students to Indian traditional medicine as part of their four-year curriculum.
